MarketInOut Stock Screener Log In | Sign Up

BioStem Technologies Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
BioStem Technologies Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization27.63 mln
Float12.66 mln
Earnings Date11/17/2026

EPS

0.88
Decent

P / E

1.27
Deeply undervalued

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.28
Borderline

Relative Strength

2 / 100
Severely lagging

Debt / Equity

0.04
Debt-free

Business Description

BioStem Technologies is a Florida-based medical company that creates and sells tissue grafts derived from placental material, primarily used to treat wounds and support tissue repair. Its product lineup includes several protective coverings for soft tissue wounds, an option designed for eye surface repair, and human connective tissue matrices. Founded in 2006 and operating exclusively in the United States, the company serves the growing field of advanced wound care.

Key Fundamentals

EPS0.88
P/E1.27
ROE-71.90
RPS2.04
ROIC-55.00
ROA-42.98
EBITDA, mln-22.09
EV / EBITDA-2.16
EV / EBIT-2.02
Revenue, mln34.59
EV / Revenue1.38

Quote Details

Last 1.12
Change -0.17 (-13.18%)
Open 1.29
Volume 145,013
Turnover 162,415
Average Volume 151,360

Financial Ratios

Pre-Tax Profit Margin-68
Leverage Ratio1.77
Current Ratio0.98
Price / Book1.99
Price / Tangible Book11.44
Debt / Equity0.04
Price / Sales1.66

Financial Strength

Altman Z-Score-0.08
Piotroski F-Score 3 / 9
Beneish M-Score-2.28
Price to Intrinsic Value0.79
Short Ratio0.54

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -28.66% 4 / 100   
1 Month -63.52% 1 / 100   
2 Months -70.68% 3 / 100   
6 Months -74.83% 5 / 100   
1 Year -75.97% 8 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog